Top Markets
#1 ADO Protocol ADO Protocol +195.12%
#2 Islamic Coin Islamic Coin +155.34%
#3 GoPlus Security GoPlus Security +42.40%
#4 GAIB AID GAIB AID +24.67%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.58%
#6 TENDIES TENDIES +15.93%
#7 Tutorial Tutorial +14.90%
#8 Wrapped NXM Wrapped NXM +14.40%
#9 Verus Coin Verus Coin +13.64%
#10 Pons Pons +11.86%
Coin of the day
ADO Protocol ADO Protocol
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
TME Pharma N.V. TME Pharma N.V.

TME Pharma N.V.

ALTME
Classement en actions #33659
TME Pharma N.V., a biopharmaceutical company in the clinical development stage... TME Pharma N.V., a biopharmaceutical company in the clinical development stage based in Berlin, Germany, is dedicated to pioneering innovative therapeutic solutions for cancer. The company leverages its unique Spiegelmer platform to advance a pipeline of investigational drug candidates. Its primary oncology asset, NOX-A12, is currently being evaluated in clinical studies as a combination therapy for a range of challenging cancers, including metastatic pancreatic and colorectal cancer, glioblastoma, and myeloma. Beyond its cancer-focused efforts, TME Pharma also developed NOX-E36, which has successfully concluded Phase 1/2 clinical trials for diabetic nephropathy. The company has formed a strategic collaboration with Merck Sharp & Dohme Corp. to explore NOX-A12 in combination with Keytruda and two different chemotherapy protocols as a second-line intervention for patients battling metastatic pancreatic cancer. Founded in 1997, the organization adopted its current name, TME Pharma N.V., in July 2022, having previously operated as NOXXON Pharma N.V.
Prix de l'action
$0.07591393
Dernière synchronisation: 2026-08-14
Capitalisation boursière
$7.15M
Changement (1 jour)
3.90%
Changement (1 an)
-41.05%
Pays
DE
Échange TME Pharma N.V. (ALTME)

Catégorie

Healthcare
Historique du prix de l'action pour TME Pharma N.V. (ALTME)
Prix de clôture le plus élevé : $0.07 le 2026-08-01

Prix de clôture le plus bas : $2.42K le 2016-09-01
Historique du prix de l'action de TME Pharma N.V. de 2016 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 32.43%
2025 -15.09%
2024 -67.73%
2023 -81.54%
2022 -95.65%
2021 -45.73%
2020 27.62%
2019 -67.02%
2018 -81.06%
2017 -65.91%
2016 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE